ARNA - Arena Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue17,97021,33792,16313,398
Cost of Revenue115,02970,98863,78283,283
Gross Profit-97,059-49,65128,381-69,885
Operating Expenses
Research Development----
Selling General and Administrative47,72430,34127,52930,281
Non Recurring----
Others----
Total Operating Expenses162,753101,32991,311113,564
Operating Income or Loss-144,783-79,992852-100,166
Income from Continuing Operations
Total Other Income/Expenses Net5,949-15,862-13,152-10,541
Earnings Before Interest and Taxes-144,783-79,992852-100,166
Interest Expense-5,695-6,119-6,512-6,828
Income Before Tax-138,834-95,854-12,300-110,707
Income Tax Expense-110,265---
Minority Interest--491491
Net Income From Continuing Ops-28,569-95,854-12,300-110,707
Non-recurring Events
Discontinued Operations-8303,122-10,5962,728
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-29,399-91,407-22,516-107,979
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-29,399-91,407-22,516-107,979